Sanctioned Russian exchange Garantex is suspected of having rebranded as Grinex and relaunched, according to reports from TRM ...

Genocury launched the in vivo CD19 CAR-T therapy to reach the clinical stage, demonstrating exceptional safety, efficiency and durability. Results are attained without requiring lymphodepletion.

The number of dengue cases in Delhi has touched 118 so far this year. Though the cases are fewer compared to the previous ...

The humanitarian needs of hundreds of thousands of survivors remain desperately pressing a month after Myanmar’s deadly ...

Abeona Therapeutics Inc.’s ABEO share price has surged by 5.17%, which has investors questioning if this is right time to ...

In April, the sociological company Active Group, together with the Experts Club information and analytical center, conducted ...

Despite product stack confusion, WD's latest Black SN7100 delivers some seriously impressive performance, particularly on the ...

Enterprises continue to pay ransom demands due to compromised recovery systems and growing data extortion threats.

Today, at its MAX London creativity conference, Adobe (Nasdaq:ADBE) unveiled over one hundred all-new innovations across its ...

Lam Research Corporation’s LRCX share price has surged by 5.33%, which has investors questioning if this is right time to ...

A new malware campaign is using fake PDF converters to sneak malicious PowerShell commands onto devices, putting crypto ...

Investing.com — 周二，Jefferies维持了对市值81亿美元的AppLovin Corporation (NASDAQ:APP)的强势立场，重申该公司为其首选股票，目标价为460美元。这一背书是在一项全面的第一季度移动游戏广告技术调查之后做出的，该调查分析了超过13亿美元的应用安装支出。调查得出了三个主要见解，突显了AppLovin在市场份额方面的显著增长及其在广告调解领域的强劲 ...